<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药通社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-22T11:17:55+08:00</updated>
  <subtitle>医药：政策、资讯、产业、发展</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>刚刚！国家局药品审评检查长三角分中心挂牌了！</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/RrddRikqrmD8lPc1fVV8XA</id>
    <link href="https://mp.weixin.qq.com/s/RrddRikqrmD8lPc1fVV8XA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021，科研之路，有“懂王”伊诺凯就够了！</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/n5kXahfCzvXmJAnobxgWpQ</id>
    <link href="https://mp.weixin.qq.com/s/n5kXahfCzvXmJAnobxgWpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>日本、印度药企首吃螃蟹！疫情下：CFDI首次开展进口药品远程非现场检查试点工作</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/jdQPI_t-RiQdloPqs4f5pQ</id>
    <link href="https://mp.weixin.qq.com/s/jdQPI_t-RiQdloPqs4f5pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>累计87个参比未通过审议：CDE发布36批、37批参比制剂公示</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/zEkLq4vXx4_Wt_uQLo2VCQ</id>
    <link href="https://mp.weixin.qq.com/s/zEkLq4vXx4_Wt_uQLo2VCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费参会，议程发布！“华北地区”药物技术峰会暨仿制药一致性评价</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/Q677DoCumUzSRhDDNBbuLQ</id>
    <link href="https://mp.weixin.qq.com/s/Q677DoCumUzSRhDDNBbuLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/G1YZRj8cnBLeTObLdLJdzQ</id>
    <link href="https://mp.weixin.qq.com/s/G1YZRj8cnBLeTObLdLJdzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局关于废止原《药物研发与技术审评沟通交流管理办法》的公告（2020年第139号）</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/9bS2NE7WIHif0VlX4bXEVA</id>
    <link href="https://mp.weixin.qq.com/s/9bS2NE7WIHif0VlX4bXEVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！总局发布《生物制品批签发管理办法》2021年3月1日起施行，8章48条</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/Zw0GSMFCaeLQSzDcZ2plPA</id>
    <link href="https://mp.weixin.qq.com/s/Zw0GSMFCaeLQSzDcZ2plPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！CDE发布《化学仿制药参比制剂目录（第三十六批）》的公示，累计86个参比未通过审议</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/5BRG6vBd9ghS54e168UlIA</id>
    <link href="https://mp.weixin.qq.com/s/5BRG6vBd9ghS54e168UlIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家局：印度药企GMP整改OK，恢复进口！此前：部分生产工序未按照GMP进行管理、部分关键工艺未经验证</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/T-xohJOcxcG7frJAY9g-QA</id>
    <link href="https://mp.weixin.qq.com/s/T-xohJOcxcG7frJAY9g-QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新：多家药企申请注销《药品生产许可证》</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/rn1DXny6c2vlpp1fDwsyww</id>
    <link href="https://mp.weixin.qq.com/s/rn1DXny6c2vlpp1fDwsyww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费参会，议程发布！“华北地区”药物技术峰会暨仿制药一致性评价</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/yIECfofW9TqrobmoTuzurw</id>
    <link href="https://mp.weixin.qq.com/s/yIECfofW9TqrobmoTuzurw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/Er8HgJaM0a4BEbtXVK-9fQ</id>
    <link href="https://mp.weixin.qq.com/s/Er8HgJaM0a4BEbtXVK-9fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华为进军药物研发！医药界幸事！</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/aqCR_AJdtK8ghzVZcRoI9g</id>
    <link href="https://mp.weixin.qq.com/s/aqCR_AJdtK8ghzVZcRoI9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>分享 | 创新药物风险投资策略现状研究</title>
    <updated>2020-12-20T11:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/5VYKAX032w-JTAtvP1WVpQ</id>
    <link href="https://mp.weixin.qq.com/s/5VYKAX032w-JTAtvP1WVpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球骨质疏松症药物研发概览</title>
    <updated>2020-12-20T11:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/StAaoclUCe87xOBfRw0uCQ</id>
    <link href="https://mp.weixin.qq.com/s/StAaoclUCe87xOBfRw0uCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费参会，议程发布！“华北地区”药物技术峰会暨仿制药一致性评价</title>
    <updated>2020-12-20T11:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/meEMOp61VodTRka5hOQGWw</id>
    <link href="https://mp.weixin.qq.com/s/meEMOp61VodTRka5hOQGWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-20T11:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/eZUhGfhfPYi_x_1t8qI-ZQ</id>
    <link href="https://mp.weixin.qq.com/s/eZUhGfhfPYi_x_1t8qI-ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国化学会开启会士制度，117位创始会士，43位首届会士名单！一批医药科学家当选！</title>
    <updated>2020-12-19T20:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/20OJl2-dBo4Mz7M4blTv1g</id>
    <link href="https://mp.weixin.qq.com/s/20OJl2-dBo4Mz7M4blTv1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【演讲预告】广东国标医药李沙教授：注射剂真溶液一致性评价法规及关键技术要求</title>
    <updated>2020-12-19T20:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/4rxWAxsCZpGbVYquWhR_NQ</id>
    <link href="https://mp.weixin.qq.com/s/4rxWAxsCZpGbVYquWhR_NQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>